Factors contributing to anemia after uncomplicated falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 5, 2001, Pages 614-622

  Price, R N ^a   Simpson, J A ^a   Nosten, F ^a   Luxemburger, C ^a   Hkirjaroen, L ^a   Kuile, F T ^a   Chongsuphajaisiddhi, T ^a   White, N J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CELL LOSS; CHILD; DISEASE TRANSMISSION; FEMALE; HEMATOCRIT; HEMOLYSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PROSPECTIVE STUDY; RISK FACTOR; THAILAND;

EID: 0035208249     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.614     Document Type: Article

References (33)

1. Plasmodium falciparum-associated anemia in children at a large urban hospital in Zaire
2. The pathophysiology of malaria
3. In-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infection
4. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: Early treatment failure aggravates anaemia
5. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa
6. Anaemia, blood transfusion practices. HIV and mortality among women of reproductive age in western Kenya
7. Childhood mortality during and after hospitalisation in Western Kenya: Effect of malaria treatment regimens
8. The epidemiology of malaria in a Karen population on the western border of Thailand
9. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria
10. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria
11. Treatment of multi-drug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination
12. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria
13. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria
14. Treatment of uncomplicated hyperparasitaemic falciparum malaria on the Thai-Burmese border
15. Artesunate versus artemether for the treatment of recrudescent falciparum malaria
16. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria
17. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria
18. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
19. Alphathalassaemia in Northern Thailand
20. The importance of anaemia in cerebral and uncomplicated falciparum malaria: Role of complications, dyserythropoiesis and iron sequestration
21. Reduced erythrocyte survival following clearance of malarial parasitemia in Thai patients
22. Erythrocyte survival in severe falciparum malaria
23. In vivo removal of malaria parasites from red cells without their destruction in acute falciparum malaria
24. The pathogenesis of the anaemia of chronic disorders and the role of fever in erythrokinetics
25. Parasite-induced changes to localized erythrocyte membrane deformability in Plasmodium falciparum cultures
26. Red cell deformability as a predictor of anemia in severe falciparum malaria
27. Dynamic alteration in splenic function during acute falciparum malaria
28. Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria
29. The epidemiology of severe malaria in an area of low transmission in Thailand
30. Predictors of mefloquine treatment failure: A prospective study in 1590 patients with uncomplicated falciparum malaria
31. Treatment of vivax malaria on the western border of Thailand
32. Plasmodium vivax and P. falciparum: Biological interactions and the possibility of cross-species immunity
33. Recovery from acute haemorrhage in normal men and women